Please join the Syneos Health team for an

Analyst
& Investor Event

Please join the Syneos Health Executive Team for discussion and Q&A about the Company’s product development approach and plan to drive accelerated growth in the evolving healthcare environment.

Watch Webcast

Beat AML 2020 Update

Since 2016, Syneos Health has partnered with the Leukemia and Lymphoma Society to develop the U.S.’ first multi-site, collaborative clinical study on treatment for acute myeloid leukemia (AML).

Customer Case Study

Learn how one customer worked with our integrated Commercial Solutions team to successfully re-imagine their product launch at the start of the pandemic.

Biopharmaceutical Acceleration Model

Every aspect of Syneos Health fuels our Biopharmaceutical Acceleration Model (BAM) - and unlike traditional CROs and commercialization businesses, here, clinical and commercial work together to accelerate customer success.

Learn More

2021 Health Trends

Join us for our 11th year of reporting on the trends we predict to influence the pharmaceutical industry in 2021.

Introducing Kinetic

™

The dynamic omnichannel capability the healthcare industry has been waiting for.

Kinetic™ - Integrating Intelligence to Accelerate Impact.

Meet Kinetic™

I am an Accelerator

Meet some of the people helping shorten the distance from lab to life at Syneos Health.

2019 Sustainability Report

Our culture includes a purposeful approach to Environmental, Social and Governance (ESG) efforts, which are increasingly important to our customers and our employees.

This report highlights our purposeful actions to uphold our responsibility to create a more sustainable world for each other.

Read Our 2019 Report

Insights Hub Live

View scenes from our premiere video series, Insights Hub Live.

Go to the Insights Hub